✦ LIBER ✦

Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients

✍ Scribed by Reddy, B.K.M.; Lokesh, V.; Vidyasagar, M.S.; Shenoy, K.; Babu, K.G.; Shenoy, A.; Naveen, T.; Joseph, Bindhu; Bonanthaya, R.; Nanjundappa, ; Bapsy, P.P.; Loknatha, ; Shetty, Jayarama; Prasad, Krishna; Tanvir Pasha, C.R.

Book ID: 125441302
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 858 KB
Volume: 50
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2013.11.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, open-label study (EGF 100262)

A phase I, open-label study (EGF 100262) of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ I. El-Hariry; K. Harrington; J. Bourhis; C. Holford 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Phase I–II study with docetaxel (D), cis

Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

✍ D. Schrijvers; C. Van Herpen; J. Kerger; E. Joosens; C. Le Bouder; J. Castelijns 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Randomized controlled phase II compariso

Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Junichi Ishitoya; Hideki Matsuda; Choichi Horiuchi; Takahide Tag 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

8517 Phase I results from an open-label,

8517 Phase I results from an open-label, randomized, controlled, phase I/II study (ADVANTAGE) to evaluate the combination of different cilengitide regimens with cisplatin, 5-FU, and cetuximab in patients with recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)

✍ Brümmendorf, T.; Guigay, J.; Mesía, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A phase II study of vinorelbine (VRL), c

A phase II study of vinorelbine (VRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

✍ V. Guillem; M.A. Muñoz; R. Yaya; V. Soriano; M.A. Climent; C. Gaspar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 142 KB

8516 A phase 2 randomized trial of radio

8516 A phase 2 randomized trial of radiotherapy (RT) plus panitumumab compared to chemoradiotherapy in patients with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): interim pooled safety analysis

✍ Giralt, J.; Trigo, J.M.; Nuyts, S.; Ozsahin, M.; Markowitz, A.B.; Daisne, J.; Sk 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB